Loading...
Header Logo

Please contact mskhan2@childrensnational.org for any questions. Can't find your name in profiles ? Request a Profile

Keywords
Last Name
Institution

Acosta, Maria

TitleAssociate Professor
InstitutionChildrens National Medical Center
DepartmentGilbert NF Institute
Address111 Michigan Ave NW
Washington DC 20010
Phone(202) 4765513
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Swanson JM, Arnold LE, Molina BSG, Sibley MH, Hechtman LT, Hinshaw SP, Abikoff HB, Stehli A, Owens EB, Mitchell JT, Nichols Q, Howard A, Greenhill LL, Hoza B, Newcorn JH, Jensen PS, Vitiello B, Wigal T, Epstein JN, Tamm L, Lakes KD, Waxmonsky J, Lerner M, Etcovitch J, Murray DW, Muenke M, Acosta MT, Arcos-Burgos M, Pelham WE, Kraemer HC. Young adult outcomes in the follow-up of the multimodal treatment study of attention-deficit/hyperactivity disorder: symptom persistence, source discrepancy, and height suppression. J Child Psychol Psychiatry. 2017 Jun; 58(6):663-678. PMID: 28295312.
      View in: PubMed
    2. Morris SM, Acosta MT, Garg S, Green J, Huson S, Legius E, North KN, Payne JM, Plasschaert E, Frazier TW, Weiss LA, Zhang Y, Gutmann DH, Constantino JN. Disease Burden and Symptom Structure of Autism in Neurofibromatosis Type 1: A Study of the International NF1-ASD Consortium Team (INFACT). JAMA Psychiatry. 2016 Dec 01; 73(12):1276-1284. PMID: 27760236.
      View in: PubMed
    3. Payne JM, Barton B, Ullrich NJ, Cantor A, Hearps SJ, Cutter G, Rosser T, Walsh KS, Gioia GA, Wolters PL, Tonsgard J, Schorry E, Viskochil D, Klesse L, Fisher M, Gutmann DH, Silva AJ, Hunter SJ, Rey-Casserly C, Cantor NL, Byars AW, Stavinoha PL, Ackerson JD, Armstrong CL, Isenberg J, O'Neil SH, Packer RJ, Korf B, Acosta MT, North KN. Randomized placebo-controlled study of lovastatin in children with neurofibromatosis type 1. Neurology. 2016 Dec 13; 87(24):2575-2584. PMID: 27956565.
      View in: PubMed
    4. Das D, Vélez JI, Acosta MT, Muenke M, Arcos-Burgos M, Easteal S. Retrospective assessment of childhood ADHD symptoms for diagnosis in adults: validity of a short 8-item version of the Wender-Utah Rating Scale. Atten Defic Hyperact Disord. 2016 Dec; 8(4):215-223. PMID: 27510231.
      View in: PubMed
    5. Acosta MT, Swanson J, Stehli A, Molina BS. ADGRL3 (LPHN3) variants are associated with a refined phenotype of ADHD in the MTA study. Mol Genet Genomic Med. 2016 Sep; 4(5):540-7. PMID: 27652281; PMCID: PMC5023939.
    6. Martinez AF, Abe Y, Hong S, Molyneux K, Yarnell D, Löhr H, Driever W, Acosta MT, Arcos-Burgos M, Muenke M. An Ultraconserved Brain-Specific Enhancer Within ADGRL3 (LPHN3) Underpins Attention-Deficit/Hyperactivity Disorder Susceptibility. Biol Psychiatry. 2016 Dec 15; 80(12):943-954. PMID: 27692237.
      View in: PubMed
    7. Arcos-Burgos M, Acosta MT, Martinez AF, Muenke M, Enriori PJ, Mastronardi CA. Neural Plasticity in Obesity and Psychiatric Disorders. Neural Plast. 2016; 2016:6053871. PMID: 27144034; PMCID: PMC4838784.
    8. Acosta MT. Searching for molecular-targeted interventions for NF1 cognitive deficits in the classroom. Dev Med Child Neurol. 2015 Dec; 57(12):1088-9. PMID: 25920923.
      View in: PubMed
    9. Avery RA, Hwang EI, Ishikawa H, Acosta MT, Hutcheson KA, Santos D, Zand DJ, Kilburn LB, Rosenbaum KN, Rood BR, Schuman JS, Packer RJ. Handheld optical coherence tomography during sedation in young children with optic pathway gliomas. JAMA Ophthalmol. 2014 Mar; 132(3):265-71. PMID: 24435762; PMCID: PMC4445404.
    10. Widemann BC, Acosta MT, Ammoun S, Belzberg AJ, Bernards A, Blakeley J, Bretscher A, Cichowski K, Clapp DW, Dombi E, Evans GD, Ferner R, Fernandez-Valle C, Fisher MJ, Giovannini M, Gutmann DH, Hanemann CO, Hennigan R, Huson S, Ingram D, Kissil J, Korf BR, Legius E, Packer RJ, McClatchey AI, McCormick F, North K, Pehrsson M, Plotkin SR, Ramesh V, Ratner N, Schirmer S, Sherman L, Schorry E, Stevenson D, Stewart DR, Ullrich N, Bakker AC, Morrison H. CTF meeting 2012: Translation of the basic understanding of the biology and genetics of NF1, NF2, and schwannomatosis toward the development of effective therapies. Am J Med Genet A. 2014 Mar; 164A(3):563-78. PMID: 24443315; PMCID: PMC4150212.
    11. Acosta MT. Challenges of cognitive research in neurofibromatosis type 1. Lancet Neurol. 2013 Nov; 12(11):1040-1. PMID: 24107290.
      View in: PubMed
    12. Avery RA, Dombi E, Hutcheson KA, Acosta MT, Baldwin AM, Madigan WP, Gillespie A, Fitzgibbon EJ, Packer RJ, Widemann BC. Visual outcomes in children with neurofibromatosis type 1 and orbitotemporal plexiform neurofibromas. Am J Ophthalmol. 2013 Jun; 155(6):1089-1094.e1. PMID: 23453281.
      View in: PubMed
    13. Walsh KS, Vélez JI, Kardel PG, Imas DM, Muenke M, Packer RJ, Castellanos FX, Acosta MT. Symptomatology of autism spectrum disorder in a population with neurofibromatosis type 1. Dev Med Child Neurol. 2013 Feb; 55(2):131-8. PMID: 23163951.
      View in: PubMed
    14. Acosta MT, Bearden CE, Castellanos FX, Castellanos XF, Cutting L, Elgersma Y, Gioia G, Gutmann DH, Lee YS, Legius E, Muenke M, North K, Parada LF, Ratner N, Hunter-Schaedle K, Silva AJ. The Learning Disabilities Network (LeaDNet): using neurofibromatosis type 1 (NF1) as a paradigm for translational research. Am J Med Genet A. 2012 Sep; 158A(9):2225-32. PMID: 22821737; PMCID: PMC4074877.
    15. Arcos-Burgos M, Londoño AC, Pineda DA, Lopera F, Palacio JD, Arbelaez A, Acosta MT, Vélez JI, Castellanos FX, Muenke M. Analysis of brain metabolism by proton magnetic resonance spectroscopy (1H-MRS) in attention-deficit/hyperactivity disorder suggests a generalized differential ontogenic pattern from controls. Atten Defic Hyperact Disord. 2012 Dec; 4(4):205-12. PMID: 23012086; PMCID: PMC3508358.
    16. Acosta MT, Walsh KS, Kardel PG, Kutteruf RE, Bhatt RR, Bouton TC, Vezina LG, Packer RJ. Cognitive profiles of neurofibromatosis type 1 patients with minor brain malformations. Pediatr Neurol. 2012 Apr; 46(4):231-4. PMID: 22490768.
      View in: PubMed
    17. Chabernaud C, Mennes M, Kardel PG, Gaillard WD, Kalbfleisch ML, Vanmeter JW, Packer RJ, Milham MP, Castellanos FX, Acosta MT. Lovastatin regulates brain spontaneous low-frequency brain activity in neurofibromatosis type 1. Neurosci Lett. 2012 Apr 25; 515(1):28-33. PMID: 22433254; PMCID: PMC3363969.
    18. Kalamarides M, Acosta MT, Babovic-Vuksanovic D, Carpen O, Cichowski K, Evans DG, Giancotti F, Hanemann CO, Ingram D, Lloyd AC, Mayes DA, Messiaen L, Morrison H, North K, Packer R, Pan D, Stemmer-Rachamimov A, Upadhyaya M, Viskochil D, Wallace MR, Hunter-Schaedle K, Ratner N. Neurofibromatosis 2011: a report of the Children's Tumor Foundation annual meeting. Acta Neuropathol. 2012 Mar; 123(3):369-80. PMID: 22083253; PMCID: PMC3282898.
    19. Acosta MT, Kardel PG, Walsh KS, Rosenbaum KN, Gioia GA, Packer RJ. Lovastatin as treatment for neurocognitive deficits in neurofibromatosis type 1: phase I study. Pediatr Neurol. 2011 Oct; 45(4):241-5. PMID: 21907886.
      View in: PubMed
    20. Pineda DA, Lopera F, Puerta IC, Trujillo-Orrego N, Aguirre-Acevedo DC, Hincapié-Henao L, Arango CP, Acosta MT, Holzinger SI, Palacio JD, Pineda-Alvarez DE, Velez JI, Martinez AF, Lewis JE, Muenke M, Arcos-Burgos M. Potential cognitive endophenotypes in multigenerational families: segregating ADHD from a genetic isolate. Atten Defic Hyperact Disord. 2011 Sep; 3(3):291-9. PMID: 21779842; PMCID: PMC4131930.
    21. Huson SM, Acosta MT, Belzberg AJ, Bernards A, Chernoff J, Cichowski K, Gareth Evans D, Ferner RE, Giovannini M, Korf BR, Listernick R, North KN, Packer RJ, Parada LF, Peltonen J, Ramesh V, Reilly KM, Risner JW, Schorry EK, Upadhyaya M, Viskochil DH, Zhu Y, Hunter-Schaedle K, Giancotti FG. Back to the future: proceedings from the 2010 NF Conference. Am J Med Genet A. 2011 Feb; 155A(2):307-21. PMID: 21271647; PMCID: PMC3079924.
    22. Lorenzo J, Barton B, Acosta MT, North K. Mental, motor, and language development of toddlers with neurofibromatosis type 1. J Pediatr. 2011 Apr; 158(4):660-5. PMID: 21094952.
      View in: PubMed
    23. Acosta MT, Munasinghe J, Pearl PL, Gupta M, Finegersh A, Gibson KM, Theodore WH. Cerebellar atrophy in human and murine succinic semialdehyde dehydrogenase deficiency. J Child Neurol. 2010 Dec; 25(12):1457-61. PMID: 20445195; PMCID: PMC3155424.
    24. Acosta MT, Castellanos FX, Bolton KL, Balog JZ, Eagen P, Nee L, Jones J, Palacio L, Sarampote C, Russell HF, Berg K, Arcos-Burgos M, Muenke M. Latent class subtyping of attention-deficit/hyperactivity disorder and comorbid conditions. J Am Acad Child Adolesc Psychiatry. 2008 Jul; 47(7):797-807. PMID: 18520958; PMCID: PMC2774844.
    25. Acosta MT, Gioia GA, Silva AJ. Neurofibromatosis type 1: new insights into neurocognitive issues. Curr Neurol Neurosci Rep. 2006 Mar; 6(2):136-43. PMID: 16522267.
      View in: PubMed
    26. Acosta MT, Pearl PL. Imaging data in autism: from structure to malfunction. Semin Pediatr Neurol. 2004 Sep; 11(3):205-13. PMID: 15575415.
      View in: PubMed
    27. Barakat AJ, Pearl PL, Acosta MT, Runkle BP. 22q13 deletion syndrome with central diabetes insipidus: a previously unreported association. Clin Dysmorphol. 2004 Jul; 13(3):191-4. PMID: 15194959.
      View in: PubMed
    28. Acosta MT. Pharmacotherapy in autism: where to start? Drug Discov Today. 2004 Jun 01; 9(11):474. PMID: 15149621.
      View in: PubMed
    29. Acosta MT, Arcos-Burgos M, Muenke M. Attention deficit/hyperactivity disorder (ADHD): complex phenotype, simple genotype? Genet Med. 2004 Jan-Feb; 6(1):1-15. PMID: 14726804.
      View in: PubMed
    30. Acosta MT, Castellanos FX. Use of the "inverse neuroleptic" metoclopramide in Tourette syndrome: an open case series. J Child Adolesc Psychopharmacol. 2004; 14(1):123-8. PMID: 15142399.
      View in: PubMed
    31. Acosta MT, Pearl PL. The neurobiology of autism: new pieces of the puzzle. Curr Neurol Neurosci Rep. 2003 Mar; 3(2):149-56. PMID: 12583844.
      View in: PubMed
    32. Acosta MT, Leon-Sarmiento FE. Repetitive transcranial magnetic stimulation (rTMS): new tool, new therapy and new hope for ADHD. Curr Med Res Opin. 2003; 19(2):125-30. PMID: 12740156.
      View in: PubMed
    33. Pearl PL, Novotny EJ, Acosta MT, Jakobs C, Gibson KM. Succinic semialdehyde dehydrogenase deficiency in children and adults. Ann Neurol. 2003; 54 Suppl 6:S73-80. PMID: 12891657.
      View in: PubMed
    34. Rosser TL, Acosta MT, Packer RJ. Aicardi syndrome: spectrum of disease and long-term prognosis in 77 females. Pediatr Neurol. 2002 Nov; 27(5):343-6. PMID: 12504201.
      View in: PubMed
    35. Acosta MT, Montañez P, Leon-Sarmiento FE. Half brain but not half function. Lancet. 2002 Aug 24; 360(9333):643. PMID: 12241958.
      View in: PubMed
    36. Acosta M, Gallo V, Batshaw ML. Brain development and the ontogeny of developmental disabilities. Adv Pediatr. 2002; 49:1-57. PMID: 12214769.
      View in: PubMed
    Acosta's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Physical Neighbors Expand Description
    _